The new software works in conjunction with the company’s MultiPoint Pacing technology to automatically adjust the heart’s pacing based on real time changes in a patient’s cardiac condition.
While studies show that traditional CRT technology can improve the quality of life for some of the 23 million people globally living with congestive heart failure, not all patients respond to this conventional treatment.
St. Jude Medical’s SyncAV CRT technology now provides additional options for physicians and patients to maximize the beneficial effect of CRT.
“The SyncAV CRT algorithm dynamically individualizes programming to work towards providing patients with the right settings at the right time helping offer the best possible outcome for even our most complex patients. Our goal is to utilize the technology to improve outcomes while offering patients who do not respond to therapy with additional options for treatment,” said Timothy Betts, MD, consultant cardiologist and electrophysiologist at John Radcliffe Hospital in Oxford, England.
More articles on supply chain:
VA teams with Underwriters Laboratories to address medical device cybersecurity
FDA approves new catheterization device
Anthem expands member access to HIV/AIDS medications
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
